LSE - Delayed Quote GBp
Avacta Group Plc (AVCT.L)
At close: November 7 at 5:07 PM GMT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-14,872.00
-14,872.00
-16,432.00
-20,506.00
-10,642.00
Investing Cash Flow
-9,001.00
-9,001.00
-25,042.00
18,703.00
-21,899.00
Financing Cash Flow
-1,298.00
-1,298.00
56,904.00
232.00
51,647.00
End Cash Position
16,627.00
16,627.00
41,781.00
26,191.00
27,894.00
Capital Expenditure
-1,262.00
-1,262.00
-759.00
-1,314.00
-1,665.00
Issuance of Capital Stock
398.00
398.00
9,486.00
522.00
54,862.00
Issuance of Debt
--
--
52,250.00
--
--
Free Cash Flow
-16,134.00
-16,134.00
-17,191.00
-21,820.00
-12,307.00
12/31/2020 - 9/8/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HVO.L hVIVO plc
27.35
-1.62%
ROQ.L Roquefort Therapeutics plc
4.5500
-18.75%
BSFA.L BSF Enterprise Plc
3.5000
0.00%
FARN.L Faron Pharmaceuticals Oy
152.50
-3.17%
TRX.L Tissue Regenix Group plc
62.00
+1.64%
SNG.L Synairgen plc
4.8500
+6.36%
POLB.L Poolbeg Pharma PLC
9.10
+1.11%
ONT.L Oxford Nanopore Technologies plc
133.10
+1.29%
FUM.L Futura Medical plc
38.40
0.00%
APH0.F Ampio Pharmaceuticals, Inc.
3.6200
0.00%